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Abstract: Systemic cobalt (Co) and chromium (Cr) concentrations may be elevated in patients with
metal joint replacement prostheses. Several studies have highlighted the detrimental effects of
this exposure on bone cells in vitro, but the underlying mechanisms remain unclear. In this study,
we use whole-genome microarrays to comprehensively assess gene expression in primary human
osteoblasts, osteoclast precursors and mature resorbing osteoclasts following exposure to clinically
relevant circulating versus local periprosthetic tissue concentrations of Co2+ and Cr3+ ions and
CoCr nanoparticles. We also describe the gene expression response in osteoblasts on routinely used
prosthesis surfaces in the presence of metal exposure. Our results suggest that systemic levels of
metal exposure have no effect on osteoblasts, and primarily inhibit osteoclast differentiation and
function via altering the focal adhesion and extracellular matrix interaction pathways. In contrast,
periprosthetic levels of metal exposure inhibit both osteoblast and osteoclast activity by altering
HIF-1α signaling and endocytic/cytoskeletal genes respectively, as well as increasing inflammatory
signaling with mechanistic implications for adverse reactions to metal debris. Furthermore, we
identify gene clusters and KEGG pathways for which the expression correlates with increasing
Co2+:Cr3+ concentrations, and has the potential to serve as early markers of metal toxicity. Finally,
our study provides a molecular basis for the improved clinical outcomes for hydroxyapatite-coated
prostheses that elicit a pro-survival osteogenic gene signature compared to grit-blasted and plasma-
sprayed titanium-coated surfaces in the presence of metal exposure.
Keywords: hip replacement; osteoblasts; osteoclasts; cobalt; chromium; gene expression; microarray;
prosthesis surface
1. Introduction
The observed early failure rate for joint replacement prostheses that use a metal-on-
metal (MoM) bearing have highlighted the adverse effects of cobalt (Co) and chromium (Cr)
on tissue in the periprosthetic environment [1,2]. Tribocorrosion at the bearing surfaces of
MoM prostheses, and at modular junctions of all hip prostheses, causes persistent elevation
of Co and Cr levels both locally and systemically.
Clinically, we have reported that patients with MoM hip resurfacings and relatively
higher circulating concentrations of Co and Cr (in the interquartile range 1 to 7 µg/L) have
reduced bone turnover systemically and increased total bone mineral density compared to
individually matched patients with a conventional metal-on-polyethylene (MoP) bearing
hip prostheses [3]. There is also extensive evidence that suggests detrimental effects of
metal exposure on the survival and function of several cell types including monocytes,
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macrophages and bone cells in vitro [4–8]. However, the molecular mechanisms for these
effects remain unclear.
A recent RNA-seq-based study compared synovial tissues from patients with adverse
reaction to metal debris (ARMD) to those from patients with MoP and reported changes
in genes associated with redox homeostasis and macrophage activation [9]. Another
study that investigated the effects of Co and Cr exposure in osteoblast-like cells using
an osteogenic gene-panel, at supra-physiological concentrations (250 µM: ~12,500 µg/L),
reported down-regulation of genes involved in TGF-beta signaling and collagen produc-
tion [10]. While these studies increase our understanding of the effects metal exposure may
have in the periprosthetic environment, they fail to provide a comprehensive transcriptome-
wide insight into the response of primary human osteoblasts and osteoclasts exposed to
clinically equivalent systemic concentrations of metal exposure.
We have previously shown that routinely used topographical and chemical alteration
of prosthetic surfaces alter the physiological response of osteoblast-like cells to clinically
relevant levels of metal exposure [7]. We observed a smaller reduction in osteogenic
activity of SaOS-2 cells following Co and Cr exposure when grown on hydroxyapatite-
coated surfaces (HA) compared to those grown on grit-blasted (GB) or plasma-sprayed
titanium-coated (Ti) surfaces, with implications for osseointegration of the prosthesis. The
molecular mechanisms that mediate this relative protective effect also remains unknown.
In this study, we use whole-genome microarrays to assess differential gene expression
in primary human osteoblasts and osteoclasts grown in vitro, and in osteoblasts grown on
different prosthesis surfaces following exposure to clinically relevant concentrations of Co
and Cr.
2. Results
2.1. Effect of Cobalt and Chromium Exposure on Primary Human Osteoblasts
For osteoblasts grown in vitro on tissue culture plates and exposed to systemic con-
centrations of metal ions observed for well-functioning MOM prosthesis, 5 µg/L Co2+:Cr3+
did not significantly alter gene expression compared to the untreated cells. In contrast,
500 µg/L Co2+:Cr3+ (equivalent to the concentration of metal ions found periprosthetically
for a well-functioning MOM prosthesis) up-regulated 25 genes (Table 1). KEGG pathway
analyses identified overrepresentation of genes associated with the HIF-1 signaling path-
way (KEGG:04066; P = 4.15 × 10−7), fructose and mannose metabolism (KEGG:00051;
P = 8.90 × 10−4) and renal cell carcinoma (KEGG:05211; P = 3.345 × 10−2) in the up-
regulated genes (Table 2). Specifically, in the HIF-1 signaling pathway, genes associated
with anaerobic metabolism and reduction in oxygen consumption (PDK-1 and PFKFB3;
Log2FC of 2.04 and 1.59 and P values of 1.1 × 10
−7 and 6.6 × 10−4 respectively), and
increase in oxygen delivery (VEGFA, Log2FC = 1.6 and P = 3.8 × 10
−4) were up-regulated.
Other known HIF-1 targets such as ANKRD37 (Log2FC = 1.89 and P = 3.6 × 10
−4) and
BNIP3 (Log2FC = 1.83 and P = 1.4 × 10
−6) were also up-regulated.
Gene probes that showed significant dose-dependent effects with increasing concen-
trations of Co2+:Cr3+ formed nine individual clusters (Figure 1, Supplementary Table S1).
Functional classification of these gene clusters identified HIF-1 signalling (P = 5.2 × 10−7;
Cluster 1) and Glycolysis/Gluconeogenesis (P = 1.02 × 10−6; Cluster 2) pathways that asso-
ciated positively with increasing concentrations. Exposure to CoCr nanoparticles (100 nanopar-
ticles of Co and Cr2O3 each per cell) did not alter the gene expression significantly.
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Table 1. Genes altered in osteoblasts following 24 h exposure to 500 µg/L Co2+:Cr3+.
Gene Log2FC p Value
PDK1 2.04 1.16 × 10−7
ANKRD37 1.89 3.63 × 10−5
APLN 1.88 3.18 × 10−5
AK4 1.85 2.78 × 10−4
BNIP3 1.83 1.41 × 10−6
PFKFB3 1.69 6.57 × 10−5
VEGFA 1.59 3.85 × 10−4
VLDLR 1.59 8.95 × 10−4
SLC2A1 1.59 6.65 × 10−4
PFKFB4 1.59 2.32 × 10−5
LOC101929947 1.51 6.00 × 10−4
TCAF2 1.47 3.20 × 10−4
ALDOC 1.46 1.53 × 10−4
ENO2 1.42 2.98 × 10−5
INHBB 1.41 1.89 × 10−4
FAM162A 1.33 8.58 × 10−6
P4HA1 1.25 1.36 × 10−4
DDIT4 1.22 5.04 × 10−4
NXPH4 1.21 3.79 × 10−4
EGLN1 1.19 4.75 × 10−5
GYS1 1.17 4.17 × 10−5
BNIP3L 1.16 9.58 × 10−6
PGK1 1.12 7.77 × 10−5
RORA 1.10 8.68 × 10−4
PPP1R3C 1.01 1.44 × 10−4
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Figure 1. Expression profiles for osteoblast gene clusters with statistically significant expression
changes with increasing concentrations of Co2+:Cr3+ (0, 5 and 500 µg/L). Corresponding heat map for
each plot is illustrated underneath. Gene list for each cluster is available in Supplementary Table S1.
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2.2. Effect of Cobalt and Chromium Exposure on Primary Human Osteoclasts
For osteoclast precursors exposed to systemic Co2+:Cr3+ concentration of 5 µg/L,
313 genes were down-regulated (Supplementary Table S2). KEGG pathway analyses identi-
fied overrepresentation of genes associated with the focal adhesion pathway (KEGG:04510;
P = 1.8 × 10−3) and ECM-receptor interaction (KEGG:04512; P = 6.3 × 10−3) among others
(Figure 2). We also observed down-regulation of genes associated with osteoclast differen-
tiation (DCSTAMP and GPER1; Log2FC = −1.87 and −1.64, P = 2.4 × 10
−3 and 2.9 × 10−3
respectively) and apoptosis (HRK and FAS; Log2FC =−1.65 and −2.3, P = 3.6 × 10
−3 and
7.3 × 10−3). This was accompanied by an increase in genes associated with epigenetic mod-
ifications (KMT5C, Log2FC = −1.53, P = 4.5 × 10
−3) and Ca2+ signaling pathways (ANO3
and SELENOP; Log2FC = −1.56 and 1.87.3, P = 6.4 × 10
















Figure 2. Functional classification of genes down-regulated in osteoclast precursors following
exposure to 5 µg/L Co2+:Cr3+. KEGG pathways that were enriched in the differentially expressed
genes, with the number of genes in each pathway and the corresponding P value are illustrated here.
Exposure to higher concentration of 500 µg/L Co2+:Cr3+ caused a down-regulation
in 467 genes, and an up-regulation in 125 genes (Supplementary Table S3). Functional
classification identified the down-regulated genes to be overrepresented in the endocytosis
pathway (KEGG:04144; P = 9.3 × 10−3). These include genes involved in both the forma-
tion of endosomes (PIP5K, Log2FC = −1.63, P = 2.1 × 10
−3; and PLD, Log2FC = −1.59,
P = 1.75 × 10−4) and its trafficking (EHD2, Log2FC = −1.60, P = 1.9 × 10
−3; and EHD3,
Log2FC = −1.73, P = 8.82 × 10
−4). Up-regulated genes were associated with the cytokine-
cytokine receptor interaction pathway (KEGG:04060; P = 1.1 × 10−13) and TNF signaling
pathway (KEGG:04668; P = 3.5 × 10−4).
Gene probes that showed significant dose-dependent effects with increasing concen-
trations of Co2+:Cr3+ formed eight individual clusters (Supplementary Table S4). Func-
tional classification of these gene clusters identified calcium signalling (KEGG:04020;
P = 1.3 × 10−3) and Ras signalling pathway (KEGG:04014; P = 3.6 × 10−3) to be enriched
in Cluster 1, which associated negatively with increasing metal concentrations (Figure 3A).
Cluster 4 which positively correlates with increasing metal concentrations (Figure 3B)
had the cytokine-cytokine receptor interaction pathway (KEGG:04060; P = 4.7 × 10−2)
enriched which included genes such as IL13RA1 and IFNGR1 that are known to reduce
osteoclast activity [11,12].
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Figure 3. Expression profiles for osteoclast precursor gene clusters with statistically significant expression changes with
increasing concentrations of Co2+:Cr3+ (0, 5 and 500 µg/L). Corresponding heat map for each plot is illustrated underneath.
(A) Cluster 1 with genes that are overrepresented in calcium signaling and Ras signaling pathway, and associate negatively
to metal concentrations, and (B) Cluster 4 have genes overrepresented in cytokine-cytokine receptor interaction pathway
and have positive association with increasing concentrations of metal ions. Gene list for all eight clusters can be found in
Supplementary Table S4.
For osteoclast precursors exposed to CoCr nanoparticles, we observed down-regulation
of 525 genes, including genes that associate with the endocytosis pathway (KEGG:04144;
P = 1.1 × 10−3), and those that regulate actin cytoskeleton (KEGG:04810; P = 8.0 × 10−3;
Supplementary Table S5). There were 121 genes up-regulated that were overrepresented
in the transcriptional misregulation in cancer pathway (KEGG:05202; P = 5.9 × 10−4),
including chromatin regulator HMGA2 (Log2FC = 1.14; P = 2.9 × 10
−3) and transcription
factor HOXA10 (Log2FC = 1.03; P = 2.98 × 10
−5).
For mature osteoclasts exposed to systemic Co2+:Cr3+ concentration of 5 µg/L, 185 genes
were down-regulated (Supplementary Table S6). Functional classification identified their as-
sociation with focal adhesion (KEGG: 04510; P = 3.4 × 10−3), ECM interaction (KEGG:04512;
P = 9.5 × 10−3) and PI3K-Akt signaling pathways (KEGG:04151; P = 4.6 × 10−2). We also
observed down-regulation of similar genes to those observed in osteoclast precursors, and
those that osteoclast differentiation (DCSTAMP and GPER1; Log2FC = −1.74 and −1.66,
P = 6.0 × 10−3 and 4.2 × 10−3 respectively).
At higher concentrations of 500 µg/L Co2+:Cr3+, as with the lower concentration
of 5 µg/L, genes from the focal adhesion (KEGG: 04510; P = 3.0 × 10−3) and PI3K-Akt
signaling pathways (KEGG: 04151; P = 2.1 × 10−2) were down-regulated. Other genes
that were associated with osteoclast survival and function that were down-regulated
included CSF1 (Log2FC = −2.38; P = 3 × 10
−4) and ITGBL1 (Log2FC = −1.62; P = 9 × 10
−3;
Supplementary Table S7). Genes known to play a role in osteoblast differentiation such as
WNT5A (Log2FC = 1.42; P = 2.03 × 10
−6) and ATF5 (Log2FC = 1.97; P = 3.1 × 10
−3) were
up-regulated at this concentration (Supplementary Table S7).
Gene probes that showed significant dose-dependent effects with increasing concen-
trations of Co2+:Cr3+ formed nine individual clusters (Supplementary Table S8). Genes
from the focal adhesion pathway (KEGG: 04510; P = 5.0 × 10−2, Cluster 6) were found to
be enriched from a cluster that negatively associated with increasing metal concentrations
(Table 3).
Table 3. KEGG pathways that associate with increasing concentrations of Co2+:Cr3+.
Pathways KEGG Cell Type Correlation p Value
HIF1- signaling 04066 Osteoblasts Positive 5.2 × 10−7
Glycolysis/Gluconeogenesis 00010 Osteoblasts Positive 1.02 × 10−6
Ca2+ signaling 04020 Osteoclast precursors Negative 1.3 × 10−3
Ras signaling 04014 Osteoclast precursors Negative 3.6 × 10−3
Cytokine-cytokine receptor interaction 04060 Osteoclast precursors Positive 4.7 × 10−2
Focal Adhesion 04510 Mature osteoclasts Negative 5.0 × 10−2
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Focal adhesion (KEGG: 04510; P = 5.4 × 10−4) and endocytosis (KEGG:04144;
P = 2.5 × 10−3) were the primary pathways down-regulated in mature osteoclasts exposed
to CoCr nanoparticles. Specifically, integrins ITGA3 (Log2FC = −1.03; P = 4.9 × 10
−3) and
ITGB3 (Log2FC = −1.89; P = 8.9 × 10
−4), and cytoskeletal genes PXN (Log2FC = −1.36;
P = 1.27 × 10−4) and FLNB (Log2FC = −1.41; P = 1.17 × 10
−4) were down-regulated in the
focal adhesion pathway. Endocytosis associated genes included PIP5K (Log2FC = −2.1;
P = 6.3 × 10−4), EHD2 (Log2FC = −2.92; P = 5.9 × 10
−4), EHD3 (Log2FC = −1.94;
P = 5.8 × 10−4), and RAB11FIP1 (Log2FC = −1.52; P = 4.8 × 10
−4). IL6 (Log2FC = 1.51;
P = 7.06 × 10−4) and SELENOP (Log2FC = 2.08; P = 2 × 10
−3) both of which are implicated
in osteoclast activity and Ca2+ homeostasis were up-regulated (Supplementary Table S9).
2.3. Effect of Cobalt and Chromium Exposure on Primary Human Osteoblasts on
Prosthesis Surfaces
For osteoblasts grown on prosthesis surfaces in the absence of metal exposure, we did
not observe significant alteration in gene expression between cells on GB and Ti surfaces.
For cells grown on HA surfaces, we observed an up-regulation in 40 genes compared
to cells grown on GB surfaces. While no KEGG pathway was identified for these genes,
we observed increased expression in BMP2 (Log2FC = 2.6; P = 4.71 × 10
−7) and SPP1
(Log2FC = 2.78; P = 3.9 × 10
−4) which are associated with increased osteoblast differen-
tiation (Supplementary Table S10). When comparing cells on HA surfaces to those on Ti
surfaces, we observed 69 genes down-regulated on Ti surfaces (Supplementary Table S11),
of which 12 were common to those expressed at lower levels on GB surfaces including
BMP2 and SPP1.
Following metal exposure at periprosthetic concentrations of Co2+:Cr3+ (1000 µg/L),
the expression profile for osteoblasts on GB surfaces was similar to that of cells on Ti
surfaces with only three genes differentially regulated. We observed an up-regulation of
TSPAN13 (Log2FC = 1.13; P = 9.75 × 10
−4), GUCY2G (Log2FC = 1.01; P = 9.77 × 10
−4) and
UBE2DNL (Log2FC = 1.02; P = 9.79 × 10
−3) for cells on GB surfaces compared to those on
Ti surfaces. In comparison, cells on HA surfaces had 69 probes down-regulated with no
specific KEGG pathway enriched for the down-regulated genes (Supplementary Table S12).
Several genes that were down-regulated on HA surfaces are known to play a vital role
in cell cycle progression and mitosis including CCNB2 (Log2FC = −1.3; P = 3.5 × 10
−3),
KIF22 (Log2FC = −1.33; P = 1.1 × 10
−3), CDCA2 (Log2FC = 1.10; P = 5.2 × 10
−3) and
CENPN (Log2FC = −1.18; P = 5.5 × 10
−3). Genes that were up-regulated on HA surfaces
compared to GB surfaces included those that influence osteoblast differentiation including
BMP2 (Log2FC = 2.66; P = 2.56 × 10
−6), SPP1 (Log2FC = 2.61; P = 3.09 × 10
−4) and OMD
(Log2FC = 1.15; P = 7.1 × 10
−3). We also observed genes from the Glycerolipid metabolism
pathway (KEGG: 00561; P = 7.09 × 10−3) to be up-regulated in cells from HA surfaces
compared to GB (Supplementary Table S12).
In the presence of periprosthetic concentrations of Co2+:Cr3+ ions (1000 µg/L), os-
teoblast grown on HA surfaces had higher expression of genes associated with osteoblast
differentiation and mineralization compared to cells on Ti surfaces, similar to those ob-
served with GB surfaces. We observed an increase in BMP2 (Log2FC = 2.71; P = 2.12 × 10
−6)
and SPP1 (Log2FC = 3.04; P = 8.58 × 10
−5) expression; inorganic pyrophosphate transporter
ANKH (Log2FC = 1.1; P = 3.9 × 10
−3), and extracellular matrix protein MGP (Log2FC = 2.22;
P = 7.8 × 10−3) which regulate mineralization. RAB27B, a gene responsible for vesicu-
lar trafficking was also up-regulated on HA surfaces (Log2FC = 1.4; P = 9.71 × 10
−5;
Supplementary Table S13).
Following CoCr nanoparticle exposure, we did not observe large-scale alterations in
gene expression between osteoblasts on GB surfaces and Ti surfaces. The only differential
expression we observed was a down-regulation in MX1 (Log2FC = −1.39; P = 3.7 × 10
−3)
and an up-regulation in GRIN3A (Log2FC = −1.12; P = 1.1 × 10
−3) expression in cells on
GB surfaces compared to Ti surfaces. Genes enriched in the necroptosis pathway (KEGG:
04217; P = 1.18P × 10−5) were down-regulated for cells on HA surfaces compared to GB
surfaces. Other pathways that were enriched with the down-regulated genes included
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alcoholism (KEGG: 05034; P = 6.89P × 10−7) and Systemic lupus erythematosus (KEGG:
05322; P = 5.64 × 10−8). Specifically, several genes from the H2 and H3 histone family that
are common between the enriched pathways were down-regulated in osteoblasts on HA
surfaces (Supplementary Table S14). A similar set of genes to those observed following
ionic exposure, had higher expression on HA surfaces compared to both GB and Ti surfaces,
including BMP2, SPP1 and ANKH (Supplementary Tables S14 and S15).
3. Discussion
The detrimental effect of prostheses-derived Co and Cr debris on the survival and
function of bone cells is well established. However, little is known about the molecular
mechanisms that mediate these effects. In this study, we used genome-wide microarrays
to obtain a comprehensive insight into the response of primary human osteoblasts and
osteoclasts at clinically relevant concentrations of 5 µg/L and 500 µg/L Co and Cr ions
representing systemic and periprosthetic metal exposure in the setting of a well-functioning
prosthesis, as well as CoCr nanoparticles. We also identify gene clusters and KEGG
pathways for which the expression correlates with increasing Co2+:Cr3+ concentrations
(Table 3). Furthermore, we describe the effects of routinely used grit-blasted, plasma-
sprayed titanium and hydroxyapatite prosthetic surfaces on primary osteoblast gene
expression without, and following, metal exposure.
3.1. Systemic Levels of Metal Exposure Inhibit Osteoclast Differentiation and Function
Total-body bone mineral density has been reported to be 5% higher in patients with
well-functioning MoM hip resurfacing with median systemic concentrations of Co and Cr
at 1.48 µg/L and 2.5 µg/L respectively, compared to those with conventional metal-on-
polyethylene (MoP) prosthesis with >10 times lower metal ion levels [3]. This is accom-
panied by a decrease in serum markers of osteoclast and osteoblast activity suggesting
reduced bone turnover. The results from this current study are consistent with these obser-
vations, and show down-regulation of genes associated with osteoclast differentiation and
function in osteoclast precursors as well as mature osteoclasts at a comparable concentra-
tion of 5 µg/L Co2+:Cr3+. This, accompanied by lower transcription of genes associated
with the focal adhesion and ECM interaction pathways that promote osteoclast differen-
tiation via increasing RANK expression [13], further supports a reduction in osteoclast
activity at systemic concentrations of metal ions.
The absence in alterations of gene expression in osteoblasts at this concentration
suggests that the reduced systemic osteoblast activity observed in patients may be a result
of de-coupling in osteoclast-mediated osteoblast function [14,15], and not a direct effect
on osteoblasts themselves. This is further supported by previous reports that show no
significant effect on osteoblast survival and function at equivalent concentrations [7]. Taken
together, our data suggests that the systemic increased total-body bone mineral density may
primarily be due to the direct inhibitory effects of metal ions on osteoclast differentiation
and resorptive function.
3.2. Periprosthetic Levels of Metal Exposure Inhibit Differentiation and Function of Osteoblasts
and Osteoclasts
At higher concentrations of 500 µg/L Co2+:Cr3+, equivalent to those observed in the
periprosthetic milieu [16], increased expression of genes such as PDK-1, VEGFA and BNIP3
that are associated with HIF-1 signaling pathway was observed in osteoblasts. Cobalt
chloride is a well-recognized hypoxia mimetic that stabilizes HIF-1α and therefore this is
an expected observation [17,18]. Nevertheless, the data is consistent with a recent clinical
study that reported up-regulation of HIF-1α target genes in the periprosthetic tissue of
patients with MoM hip replacement undergoing revision surgery [19]. HIF-1α stabilization
seems to be a localized periprosthetic effect as a separate study did not observe any
correlation in serum HIF1α levels in MoM patients with higher chronic metal exposure [20].
Additionally, the absence of an effect on HIF-1 signaling in osteoclast precursors or mature
osteoclasts suggests that hypoxic signaling may be limited to cells of mesenchymal origin.
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This is supported by a previous study in which we observed lower uptake of Co2+ in
mature osteoclasts compared to human osteoblast-like cells [21]. Furthermore, genes
associated with fructose and mannose pathways (PFKB3, PFKB4 and ALDOC, Table 2)
that were up-regulated in osteoblasts are likely to be secondary to HIF-1α signaling, and
represent a shift to a more glycolytic metabolic mode to sustain cellular energy needs, as
shown previously [22,23]. The evidence for the effects of hypoxic signaling in osteoblasts
is conflicting. Utting et al. (2006) show that hypoxic signaling inhibits differentiation
and bone-forming capacity of primary rat osteoblasts [24]. Conversely, a study in murine
models demonstrated that stabilization of HIF-1α and the shift to glycolytic metabolism
increases osteoblast numbers and induces bone formation [25]. In our previous study, we
observed that exposure to 500 µg/L Co2+:Cr3+ does increase osteoblast mineralization
in vitro, without affecting cell survival [7]. However, the effect of hypoxic signaling on
the quality of the mineralized matrix remains unclear. In a recent study, Stegen et al.
(2019) show that while stabilization of HIF-1α increases collagen crosslinking and mineral
deposition, the metabolism of collagen is altered leading to skeletal dysplasia [26].
A small proportion of patients with MoM hip replacement present with a local in-
flammatory reaction to metal debris referred to as ARMD, characterised by macrophage
and lymphocytic infiltrate [27,28]. In osteoclast precursors, which are cells derived from
the same myeloid lineage as macrophages, we observe an up-regulation of immune
chemoattractants (CCL1 and CCL23), and inflammatory cytokines (IL-1β and IL-6) from the
chemokine-chemokine signaling pathway that may partially explain the mechanism for
ARMD. While no studies have investigated the effect of combined CoCr metal exposure
on gene expression in these cells, a previous study observed an up-regulation in cytokine
and chemokine genes including IL-1β and IL-6 in peripheral blood monocytes following
Co2+ exposure alone [29]. Endocytosis and membrane trafficking were shown to be es-
sential in fusion of osteoclast precursors as well as in maintaining resorption activity in
mature osteoclasts [30,31]. Down-regulation of genes associated with endocytic and actin
cytoskeletal pathways following ionic and particulate metal exposure suggests reduced os-
teoclast differentiation from its precursors in the periprosthetic environment. Additionally,
a similar reduction in differentiation and function of mature osteoclasts is suggested with
down-regulation of focal adhesion, endocytosis and PI3K-AKT pathways [13,32–34].
Taken together with the effect on osteoblasts, the data suggests that bone turnover may
be inhibited in the periprosthetic microenvironment, with implications for osseointegration
and eventual failure of the prosthesis.
3.3. Pathways with a Dose-Dependent Effects to Metal Ions
In this study, we identified gene clusters for both osteoblasts and osteoclasts, with
significant dose-dependent correlations with increasing concentrations of Co2+:Cr3+. The
positive correlation for genes associated with HIF-1 signaling (such as VEGFA, PDK1, ENO2
and SLC2A1) and Glycolysis/Gluconeogenesis pathways (PGM1, TPI1 and PGK1) with
metal exposure in osteoblasts confirm them as the primary response in these cells. This
dose-dependent increase in the genes from the Glycolysis/Gluconeogenesis pathway is
consistent with a recent study that showed an increase in glycolytic parameters including
increased lactate production in macrophages exposed to Co2+ and Cr3+. The study also
demonstrated that this shift to glycolysis is downstream of HIF-1α stabilization, an effect
primarily attributed to Co2+ [18].
Similarly, genes from the cytokine-cytokine receptor interaction pathway (CXCL4,
CXCR5, IL13RA1, CD27) in osteoclast precursors and focal adhesion pathways (DIAPH1,
PXN, and CCND1) in mature osteoclasts positively correlated with metal exposure. The
dose-dependent changes in the expression of these genes provides us with a possible
gene-panel for which subtle changes in expression may serve as an early marker for CoCr
metal toxicity.
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3.4. Response of Osteoblasts to Prosthetic Surfaces and Metal Exposure
Prosthetic surfaces are routinely modified topographically or chemically to make them
more osseoconductive and promote osseointegration. GB, Ti and HA coating are some
of the most commonly used alterations of prosthetic surfaces. In a previous study, we
reported increased osteoblast differentiation and mineralization on HA surfaces compared
to GB and Ti surfaces, and a protective effect on their osteogenic activity in the presence
of CoCr ions and nanoparticles [7]. Here we show that HA surfaces, in comparison to GB
and Ti surfaces, consistently promote expression of BMP2 in osteoblasts which is known
to increase alkaline phosphatase activity and mineralization in an autocrine manner [35].
This increase in BMP2 expression on HA surfaces seems to be a conserved response with
studies showing its up-regulation in smooth muscle cells and periodontal ligament cells
when cultured on HA surfaces [36,37].
Even with exposure to periprosthetic concentrations of CoCr ions and nanoparticles,
BMP2 and FOSB expression that mediate osteoblast differentiation, and SPP1 (osteopontin)
a marker for mature osteoblasts, were consistently up-regulated. This, accompanied by a
reduction in genes associated with necroptosis (HIST2H3A, HIST1H2AM, and HIST1H2AK)
and cell cycle progression (CCNB2 and CDCA2), suggests that osteoblasts on HA surfaces
possess a pro-survival and differentiation state compared to those grown on GB and Ti sur-
faces, with implications for osseointegration. Indeed, these results translate clinically. In the
National Joint Registry for England and Wales, the largest joint replacement clinical audit
in the world, the 5-year revision rates for hydroxyapatite-coated Birmingham and Adept
hip resurfacing systems are 3.66% (95% CI; 3.42–3.92) and 4.52% (3.87–5.27) respectively,
compared to 8.3% (6.93–9.93) for Conserve Plus and 5.47% (4.48–6.66) for the Durom system
that use a plasma-sprayed titanium coating [38]. Finally, the up-regulation of glutamate
receptor GRIN3A on GB surfaces compared to Ti surfaces may explain the increased miner-
alization observed on these surfaces in vitro [7]. Glutamate signaling was indeed shown
to increase osteoblast differentiation and function [39], and the up-regulation of GRIN3A
may partly be a result of differential cell adhesion to the different surface roughness of the
two materials [40].
Our study also has limitations. While the high threshold for differentially expressed
genes used in this study gives us confidence in our findings, validation of transcripts
for select genes using RT-PCR, and the resultant proteins with western blotting, would
be useful. Furthermore, investigating gene responses for osteoblasts and osteoclasts in
isolation although vital to discern direct effects of metal exposure, discounts the complex
inter-cellular coupling that exists between osteoblasts and osteoclasts to maintain bone
homeostasis, and using co-culture systems or in silico modeling could help better under-
stand tissue-level effects. Finally, the use of Co and Cr ion combinations at the ratio of 1:1
is an approximation of the clinical setting after hip resurfacing. This may differ for MoM
total hip replacements and vary between patients.
In conclusion, this study provides a comprehensive mechanistic understanding of
the direct effects prosthesis derived Co and Cr have on primary human osteoblasts and
osteoclasts in both the systemic and local periprosthetic environment. Furthermore, for
the first time, to the best of our knowledge, several gene clusters and pathways that are
regulated in a dose-dependent manner in bone cells are identified here, which could serve
as early markers for metal toxicity. Finally, we provide a mechanistic basis for the improved
clinical performance of hydroxyapatite-coated prostheses.
4. Materials and Methods
4.1. Metal Ion Preparation and Treatment
Cobalt (II) hexahydrate (CoCl2.6H2O) and chromium (III) chloride hexahydrate
(CrCl3.6H2O) (Fluka, Gillingham, UK) served as salts for Co2+ and Cr3+, respectively.
For each metal salt, 0.2 M stock solutions were prepared in sterile water and serially diluted
to 100× working concentrations. Subsequently, equal volumes of Co2+ and Cr3+ solutions
(Co2+:Cr3+) were added to culture media to get the final treatment concentrations. The
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stability of these metal ions in culture media has been confirmed previously using flame–
atomic absorption spectroscopy [4]. Control treatment contained equivalent volume of
sterile distilled water to maintain conditions and are referred to as 0 µg/L treatments.
Co and Cr2O3 nanoparticles (a kind gift from Dr Ferdinand Lali, Imperial College,
London, UK) were 40 nm and 30 nm in size respectively. Both osteoblasts and osteoclasts
were treated with 100 nanoparticles each of Co and Cr2O3 per cell (CoCr nanoparticles),
based on their seeding densities. Using the specific surface area (SSA) of the nanoparticles
(50 m2/gm for Co, and 140 m2/gm for Cr2O3), and the surface area of a sphere (4πr
2),
we deduced the approximate particle number per gram of nanoparticles. These calcu-
lations were used to form a 1000× stock of the working concentration in 100% ethanol.
Prior to treatments, the suspension was sonicated for 10 min to disaggregate the particles
and diluted in osteogenic media to obtain the working concentration. Control treatment
contained equivalent volume of ethanol to maintain conditions.
4.2. Primary Human Osteoblast Culture
Primary human osteoblasts were obtained from trabecular bone explants of patients
undergoing joint replacement surgery following approval by South Yorkshire and Northern
Derbyshire Musculoskeletal Biobank and approved by the National Research Ethics Ser-
vice (15/SC/0132; Study reference: SYNDMB031), and all patients gave informed written
consent prior to participation [41]. Briefly, the trabecular bone fragments were diced and
washed thoroughly with PBS and cultured in petridishes with complete media contain-
ing DMEM GlutaMAX supplemented with 10% FBS, 100 U/mL penicillin, 100 µg/mL
streptomycin and 2.5 µg/mL Amphotericin-B (Gibco, Paisley, UK). After a week, the me-
dia was replaced twice weekly for a further 4–6 weeks till the explant cultures reached
confluence. The osteoblast-like phenotype of these cells was confirmed by assessing their
alkaline phosphatase activity and their ability to mineralize in vitro, and was described
previously [7]. Subsequently, cells were cultured in vitro on tissue culture plates, or on GB,
Ti and HA coated prosthesis surfaces (supplied by JRI Orthopaedics Ltd., Sheffield, UK)
that better mimic the periprosthetic physiological setting and were manufactured using
the same processes as used commercially.
Osteoblasts grown in tissue culture plates were treated with a combination of 0, 5, and
500 µg/L of Co2+:Cr3+ to mimic the systemic concentrations observed following metal-on-
metal hip resurfacing. For cells grown on prosthetic surface, periprosthetic concentrations
of 1000 µg/L Co2+:Cr3+ were used. In both cases, the osteoblasts were exposed to the
different concentrations of metal ions for 24 h. Previous clinical reports on the levels of
circulating and periprothetic Co and Cr has informed the use of these concentrations in
this study [42–45].
4.3. Primary Human Osteoclast Culture
Primary human osteoclasts were generated as described previously from human
peripheral blood of healthy volunteers following research ethics committee approval [46].
Briefly, CD14+ enriched monocyte population was isolated from peripheral blood and
seeded onto sterile dentine disks in osteoclastogenic media containing α-MEM GlutaMAX
supplemented with 10% FBS, 100 U/mL penicillin, 100 µg/mL streptomycin (Gibco, Paisley,
UK), 25 ng/mL M-CSF (R&D Systems, Abingdon, UK) and 30 ng/mL RANKL (R&D
Systems, Abingdon, UK), and cultured in humidified incubator at 37 ◦C and 7% CO2. To
investigate the effects of metal ions on developing osteoclasts, the metal ion treatments were
added at day 3, and replaced every 2–3 days until the onset of resorption. To investigate
the effects on mature osteoclasts, metal ion treatments were added for 24 h after the onset
of resorption (typically day 14).
Both developing and mature osteoclasts were treated with 0, 5 and 500 µg/L of
Co2+:Cr3+ to mimic systemic concentrations observed following metal-on-metal hip resurfac-
ing. The developing osteoclasts were treated continuously til 24 h after the onset of resorption
while mature osteoclasts were treated once for 24 h following the onset of resorption.
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4.4. RNA Extraction and Gene Expression
Following exposure to metal ion treatments, the cells were washed twice with ice-
cold PBS and total RNA extracted using the RNeasy Extractions Kits (Qiagen, Hilden,
Germany) as per manufacturer’s protocol and the quality checked using the Agilent 2200
TapeStation (Agilent Technologies, Santa Clara, CA, USA). Gene expression profiling was
performed using Agilent SureprintG3 Gene Expression Microarrays (8 × 60 K format)
(Agilent Technologies, Santa Clara, CA, USA). Total RNA from was labeled with cyanine-
3 CTP and hybridized to the array as per manufacturer’s instructions, the arrays read
using the Agilent Microarray Scanner, and the data extracted with Feature Extraction v10.7
(Agilent Technologies, Santa Clara, CA, USA).
4.5. Data Analyses
The microarray data were imported into R using the ‘limma’ Bioconductor package
for quality assessment and processing [47]. Three arrays were removed from the Osteo-
clasts dataset due to significant spatial artifacts present on the raw images. Background
correction was performed using the normexp method in limma and signal between arrays
was calibrated using quantile normalization. The normalized data were then filtered to
the set of 50% most variable probes in order to increase the power to detect differential
expression [48]. Differentially expressed probes were identified using a linear model ap-
proach followed by empirical Bayes shrinkage and the threshold was set at Log2FC > 1
and P < 0.001 [47]. DAVID (Ver. 6.8) was used to conduct KEGG enrichment analysis of
differentially expressed genes [49,50]. The Benjamini-Hochberg corrected p value < 0.05
was set as the threshold for statistically significant enrichment. In a separate analysis, genes
with an association between expression level and concentration were identified using the
maSigPro Bioconductor package [51].
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